KEGG   PATHWAY: bbis04650
Entry
bbis04650                   Pathway                                
Name
Natural killer cell mediated cytotoxicity - Bison bison bison (American bison)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
bbis04650  Natural killer cell mediated cytotoxicity
bbis04650

Other DBs
GO: 0042267
Organism
Bison bison bison (American bison) [GN:bbis]
Gene
104979739  VAV1; LOW QUALITY PROTEIN: proto-oncogene vav [KO:K05730]
104979830  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
104979900  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
104980033  PTPN11; tyrosine-protein phosphatase non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
104980493  PLCG1; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
104980820  ZAP70; tyrosine-protein kinase ZAP-70 isoform X1 [KO:K07360] [EC:2.7.10.2]
104981582  NRAS; GTPase NRas [KO:K07828]
104981704  VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730]
104983330  VAV2; guanine nucleotide exchange factor VAV2 [KO:K05730]
104983695  [KO:K05415]
104983770  TNF; tumor necrosis factor isoform X1 [KO:K03156]
104983776  NCR3; natural cytotoxicity triggering receptor 3 isoform X1 [KO:K06743]
104983814  [KO:K07985]
104984070  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
104984204  [KO:K04722]
104984678  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
104984810  [KO:K05414]
104984916  ITGB2; integrin beta-2 [KO:K06464]
104985118  NFATC2; LOW QUALITY PROTEIN: nuclear factor of activated T-cells, cytoplasmic 2 [KO:K17332]
104985206  TNFSF10; tumor necrosis factor ligand superfamily member 10 isoform X1 [KO:K04721]
104985495  SH3BP2; LOW QUALITY PROTEIN: SH3 domain-binding protein 2 [KO:K07984]
104985507  [KO:K05414]
104985538  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
104985678  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
104986377  LCK; tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
104986605  LAT; linker for activation of T-cells family member 1 isoform X1 [KO:K07362]
104986661  ITGAL; integrin alpha-L [KO:K05718]
104986737  PRKCB; protein kinase C beta type [KO:K19662] [EC:2.7.11.13]
104986748  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
104987094  CD48; CD48 antigen [KO:K06479]
104987099  CD244; natural killer cell receptor 2B4 isoform X1 [KO:K06582]
104987424  SHC1; SHC-transforming protein 1 isoform X1 [KO:K06279]
104987521  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
104988263  SHC4; SHC-transforming protein 4 [KO:K17449]
104988719  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
104989082  [KO:K05414]
104989203  [KO:K07986]
104989204  RAET1E; NKG2D ligand 4 [KO:K07987]
104989270  [KO:K07986]
104989472  [KO:K06523]
104989779  IFNG; interferon gamma [KO:K04687]
104989942  NCR1; natural cytotoxicity triggering receptor 1 isoform X1 [KO:K06741]
104990277  SOS2; son of sevenless homolog 2 [KO:K03099]
104991008  [KO:K01353] [EC:3.4.21.79]
104991009  [KO:K01353] [EC:3.4.21.79]
104991014  [KO:K01353] [EC:3.4.21.79]
104991016  [KO:K01353] [EC:3.4.21.79]
104991667  IFNGR1; interferon gamma receptor 1 [KO:K05132]
104991966  SHC2; SHC-transforming protein 2 [KO:K17447]
104992083  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
104992086  SHC3; SHC-transforming protein 3 [KO:K17448]
104992168  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
104992258  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
104992445  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
104992549  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
104992606  [KO:K05414]
104992716  [KO:K02649]
104992794  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
104992961  CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453]
104994333  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
104994580  [KO:K04722]
104994644  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
104994732  [KO:K05414]
104995056  [KO:K05414]
104995264  HCST; hematopoietic cell signal transducer [KO:K07988]
104995265  TYROBP; TYRO protein tyrosine kinase-binding protein isoform X1 [KO:K07992]
104995620  [KO:K04371] [EC:2.7.11.24]
104995820  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
104996058  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
104996105  [KO:K07293] [EC:3.1.3.48]
104996149  [KO:K05415]
104996518  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
104996675  [KO:K05414]
104997473  PRF1; perforin-1 [KO:K07818]
104997505  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
104997583  [KO:K05414]
104998177  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
104998445  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
104998750  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
104998897  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
104999018  [KO:K08845] [EC:2.7.11.1]
104999097  LCP2; lymphocyte cytosolic protein 2 isoform X1 [KO:K07361]
104999173  SH2D1B; SH2 domain-containing protein 1B isoform X1 [KO:K07989]
104999186  [KO:K06463]
104999381  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
104999550  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446]
104999941  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
104999951  [KO:K05414]
104999978  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
105000225  KRAS; GTPase KRas isoform X1 [KO:K07827]
105000236  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
105000345  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
105000494  ICAM2; intercellular adhesion molecule 2 isoform X1 [KO:K06523]
105000525  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
105000595  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
105000638  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
105000961  IFNB1; interferon beta [KO:K05415]
105000962  [KO:K05415]
105000963  [KO:K05415]
105000964  [KO:K05414]
105001799  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
105002135  [KO:K06516]
105002137  [KO:K06516]
105002139  [KO:K06728]
105002140  [KO:K06541]
105002145  [KO:K06541]
105002146  [KO:K06541]
105002147  [KO:K06541]
105002220  [KO:K06541]
105003125  [KO:K05414]
105003447  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
105003692  HRAS; GTPase HRas [KO:K02833]
105004619  IFNGR2; interferon gamma receptor 2 [KO:K05133]
105004621  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
105004624  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
105004742  RAF1; RAF proto-oncogene serine/threonine-protein kinase [KO:K04366] [EC:2.7.11.1]
105004807  [KO:K07986]
105004808  [KO:K07986]
105005554  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
bbis04010  MAPK signaling pathway
bbis04020  Calcium signaling pathway
bbis04060  Cytokine-cytokine receptor interaction
bbis04210  Apoptosis
bbis04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system